Wound Care News
Bringing You The Latest Wound Care news and Research
EZBra Innovation in Immediate & Ongoing Post Operative Breast Care
what is EZBra
New periodic newsletter from Innovative Dutch Wound Care Company BiologiQ
BiologiQ is an independent Dutch company, basing its operations on the view that the future of wound care lies in innovative, (bio)active and sustainable wound care products. These must be geared to stimulating the body’s own regenerative powers and be based on the latest insights into the biology of the (complex) wound. Leading criteria in the development of the BiologiQ product range are proven effectiveness, sustainability, cost-efficiency, improved time-to-heal and a better quality of life for the patient.
Evidence For Person Centered Care In Chronic Wound Care
Chronic wounds affect an estimated 2.21 per 1000 population. They are a significant source of morbidity and affect individuals physically, psychologically, socially and financially. Person-centered care is one approach to improve patient outcomes in wound care as it values patients’ perspectives, beliefs and autonomy and considers the person as a whole within the cultural context in which care is provided.
Published by Georgina Gethin in 2020. This EWMA document reviews the evidence on the use of person-centered care (PCC) in chronic wound care management and provide recommendations for practice and future research.
ATYPICAL WOUNDS Best Clinical Practice & Challenges
This EWMA document provides an overview of recent knowledge and evidence about atypical wounds, defined as wounds that cannot be placed in the primary categories of non-healing wounds.
The document provides an overview about wounds considered atypical, and present the diagnostic criteria, comorbidities and diagnostic tools for these wounds. The document present the available best documented treatment options and the various treatment options of these wounds.
Advanced Therapies iIn Wound Management
This EWMA document investigates the barriers and possibilities of advanced therapies in the next generation wound management. The document includes an introduction to the available technologies based on cellular therapies, tissue engineering and tissue substitutes, which are all technologies associated with the clinical discipline of regenerative medicine. The document also describes new treatments based on physical therapies and the potential of sensors and software.